| Literature DB >> 25684204 |
Lauren A Barclay1, Thomas E Wales2, Thomas P Garner3, Franziska Wachter1, Susan Lee1, Rachel M Guerra1, Michelle L Stewart1, Craig R Braun1, Gregory H Bird1, Evripidis Gavathiotis3, John R Engen2, Loren D Walensky4.
Abstract
BCL-2 is a negative regulator of apoptosis implicated in homeostatic and pathologic cell survival. The canonical anti-apoptotic mechanism involves entrapment of activated BAX by a groove on BCL-2, preventing BAX homo-oligomerization and mitochondrial membrane poration. The BCL-2 BH4 domain also confers anti-apoptotic functionality, but the mechanism is unknown. We find that a synthetic α-helical BH4 domain binds to BAX with nanomolar affinity and independently inhibits the conformational activation of BAX. Hydrogen-deuterium exchange mass spectrometry demonstrated that the N-terminal conformational changes in BAX induced by a triggering BIM BH3 helix were suppressed by the BCL-2 BH4 helix. Structural analyses localized the BH4 interaction site to a groove formed by residues of α1, α1-α2 loop, and α2-α3 and α5-α6 hairpins on the BAX surface. These data reveal a previously unappreciated binding site for targeted inhibition of BAX and suggest that the BCL-2 BH4 domain may participate in apoptosis blockade by a noncanonical interaction mechanism.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25684204 PMCID: PMC4384643 DOI: 10.1016/j.molcel.2015.01.014
Source DB: PubMed Journal: Mol Cell ISSN: 1097-2765 Impact factor: 17.970